30
Participants
Start Date
October 31, 2006
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2009
Cetuximab + Gemcitabine + Oxaliplatin
Cetuximab 500mg/m2, iv every two weeks Gemcitabine 1000mg/m2, iv every two weeks Oxaliplatin 100mg/m2, iv every two weeks
KH Rudolfstiftung, Vienna
Association of Research on the Biology of Liver Tumors
OTHER